Leukemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 15: Line 15:
==[[Leukemia overview|Overview]]==
==[[Leukemia overview|Overview]]==


==[[Leukemia historical perspective|Historical Perspective]]==


==[[Leukemia classification|Classification]]==


==[[Leukemia pathophysiology|Pathophysiology]]==
==Classification==


==[[Leukemia causes|Causes]]==


==[[Leukemia differential diagnosis|Differentiating Leukemia from other Diseases]]==
==Differentiating Leukemia from other Diseases==


==[[Leukemia epidemiology and demographics|Epidemiology and Demographics]]==
==Prognosis==
===5-Year Survival===


==[[Leukemia risk factors|Risk Factors]]==
* Between 2004 and 2010, the 5-year relative survival of patients with leukemia was 60.3%.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>


==[[Leukemia screening|Screening]]==
* When stratified by age, the 5-year relative survival of patients with leukemia was 68.5% and 44.1% for patients <65 and ≥ 65 years of age respectively.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>


==[[Leukemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
* Shown below is a table depicting the 5-year relative survival of patients by the type of leukemia in the United States between 2004 and 2010.


==Diagnosis==
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
 
|-
[[Leukemia staging | Staging]] | [[Leukemia history and symptoms| History and Symptoms]] | [[Leukemia physical examination | Physical Examination]] | [[Leukemia laboratory studies | Laboratory Findings]] | [[Leukemia electrocardiogram|Electrocardiogram]] | [[Leukemia chest x ray|Chest X Ray]] | [[Leukemia CT|CT]] | [[Leukemia MRI|MRI]] | [[Leukemia echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Leukemia other imaging findings|Other Imaging Findings]] | [[Leukemia other diagnostic studies|Other Diagnostic Studies]]
|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Acute lymphoblastic leukemia'''||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | '''Chronic lymphocytic leukemia'''|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Acute myeloid leukemia'''|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Chronic myeloid leukemia'''
 
|-
==Treatment==
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''5-year survival'''||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 70% || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |83.5%|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |25.4% || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |59.9%
 
|}
[[Leukemia medical therapy|Medical Therapy]] | [[Leukemia surgery|Surgery]] | [[Leukemia primary prevention|Primary Prevention]]  | [[Leukemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Leukemia future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==
[[Leukemia case study one | Case #1]]


==References==
{{Reflist|2}}


{{Blood}}
{{Blood}}

Revision as of 13:43, 21 July 2017

Template:DiseaseDisorder infobox

Leukemia Microchapters

Home

Patient Information

Overview

Classification

AML
CML
ALL
CLL

Differentiating Leukemia from other Diseases

Epidemiology and Demographics

Prognosis

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Leukaemia

Overview

Classification

Differentiating Leukemia from other Diseases

Prognosis

5-Year Survival

  • Between 2004 and 2010, the 5-year relative survival of patients with leukemia was 60.3%.[1]
  • When stratified by age, the 5-year relative survival of patients with leukemia was 68.5% and 44.1% for patients <65 and ≥ 65 years of age respectively.[1]
  • Shown below is a table depicting the 5-year relative survival of patients by the type of leukemia in the United States between 2004 and 2010.
Acute lymphoblastic leukemia Chronic lymphocytic leukemia Acute myeloid leukemia Chronic myeloid leukemia
5-year survival 70% 83.5% 25.4% 59.9%

References

  1. 1.0 1.1 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:Blood


Template:WikiDoc Sources